Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Osteosarcoma × Disulfides × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 18 Ovarian Neoplasms 13 Carcinoma, Non-Small-Cell Lung 13 Fallopian Tube Neoplasms 11 Colorectal Neoplasms 10 Pancreatic Neoplasms 8 Carcinoma, Hepatocellular 6 Urinary Bladder Neoplasms 5 Mycosis Fungoides 5 Melanoma 5 Lymphoma, T-Cell, Cutaneous 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Squamous Cell Carcinoma of Head and Neck 4 Prostatic Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Sezary Syndrome 3 Sarcoma 3 Neoplasms 3 Neoplasm Metastasis 3 Myelodysplastic Syndromes 3 Multiple Myeloma 3 Lymphoma, T-Cell 3 Leukemia, Myeloid, Acute 3 Carcinoma, Renal Cell 3 Urogenital Neoplasms 2 Urethral Neoplasms 2 Ureteral Neoplasms 2 Thyroid Neoplasms 2

Interventions

Ifosfamide 20 Methotrexate 19 Cyclophosphamide 18 Doxorubicin 16 Cisplatin 13 Gemcitabine 10 Filgrastim 10 Etoposide 10 Leucovorin 8 fludarabine 7 apatinib 7 Radiotherapy 6 Nivolumab 6 Neoadjuvant Therapy 6 Drug Therapy 6 Zoledronic Acid 5 Vincristine 5 Temozolomide 5 Mesna 5 Irinotecan 5 Granulocyte Colony-Stimulating Factor 5 Docetaxel 5 Carboplatin 5 regorafenib 4 pegfilgrastim 4 glucarpidase 4 cabozantinib 4 Topotecan 4 Surveys and Questionnaires 4 Sunitinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04668300 2025-10-09

DOSa

M.D. Anderson Cancer Center

Phase 2 Active not recruiting

Hemangiosarcoma, Liposarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡